cornellbreastcenter.com
A Phase 3, Randomized Study of Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of Patients with HER2+ Metastatic Breast Cancer Who Have Received Two Prior Anti-HER2 Therapies and Require Systemic Treatment
Dr. Linda Vahdat is seeking men and women with HER2+ metastatic breast cancer to participate in a research study. The purpose of this study is to evaluate the effectiveness of margetuximab in combi…